
Medical genomics PhD student @SangerInstitute @Cambridge_Uni from 🇦🇺
Cambridge, UK
Joined December 2016
- Tweets38
- Following162
- Followers116
- Likes178
Pinned Tweet
Very excited to share the first manuscript out of my PhD presenting our analysis into the genetic architecture of gene expression and splicing using blood RNA-seq of 4,732 blood donors from the INTERVAL study. (1/7) medrxiv.org/content/10.1101/…
Alex Tokolyi retweeted
Melioidosis kills 40% of cases, yet diagnosis remains a challenge. Many patients died before the arrival of a culture-confirmed diagnosis. With @PWongpalee and @TaoUttamapinant, we developed and validated a rapid test for melioidosis👇thelancet.com/journals/lanmi…
Alex Tokolyi retweeted
What if we could inducibly create thousands of structural variants and ecDNAs in human cells and see which ones survive?
biorxiv.org/content/10.1101/…
I’m excited to share our story on scrambling the human genome by combining prime editing, repetitive elements, and recombinases. A🧵
I'd like to give a huge shout-out to @ee_davenport as well for being an amazing, passionate, & supportive supervisor throughout my PhD
Congratulations Dr @AlexTokolyi! First PhD student of davenportlab.com to complete (can you tell I'm just a little bit proud). Huge thanks to his examiners (@kauralasoo and John Whittaker) and our team and collaborators for all their support.
All of these results are publicly available to browse and explore on our portal at: intervalrna.org.uk/
I would like to give a huge thank-you to my supervisors and senior authors @ee_davenport, @minouye271 & @dirk_paul, and the lab at the @sangerinstitute for their support throughout this project
Alex Tokolyi retweeted
Excited to share the first preprint of my PhD @sangerinstitute looking into the prevalence and genetic mechanisms of gene misexpression in 4,568 whole blood RNA-seq samples from the INTERVAL cohort. biorxiv.org/cgi/content/shor…
Alex Tokolyi retweeted
Excited to share our work on targeting Cas13 to splice junctions for isoform-specific RNA knockdown. We learned a lot about the experimental design, assessment and downstream analysis of this approach. Phenomenal effort from all involved! biorxiv.org/content/10.1101/…
Alex Tokolyi retweeted
Today I lodged a Notice of Motion calling for a judicial inquiry into Media Diversity in Australia. (Seconded by @Mon4Kooyong)
Alex Tokolyi retweeted
Pleased to announce our latest work is now live at Nature Metabolism (@natmetabolism), in which we show polygenic risk scores (PRS) can be used to identify novel and causal proteins underlying disease risk.
nature.com/articles/s42255-0…
Thread 1/9
Alex Tokolyi retweeted
1/We are thrilled to present our recent work in Genes & Health @EastLondonGenes, an amazing community-based cohort of British Pakistani and Bangladeshi individuals with linked electronic health record data: medrxiv.org/content/10.1101/…
Alex Tokolyi retweeted
Happy to announce that our preprint (my first one 😁) is finally out!
We assessed how unwanted technical variations affect microbiome data, and suggest a novel computational batch correction tool, RUV-III-NB.
@phylogeo @minouye271 @SJPamp & Agus Salim
biorxiv.org/content/10.1101/…
Assessing and removing the effect of unwanted technical variations in microbiome data biorxiv.org/cgi/content/shor… #bioRxiv
Alex Tokolyi retweeted
🎉The new and improved CoVariants.org is here! 🎉
We're hoping to make this a one-stop location to track not only the 'headline' variants, but many different #SARSCoV2 mutations & variants that scientists are keeping an eye on.
Let's take a tour of the site!
1/12














